Cindy Rose, Microsoft's chief operating officer for global enterprise sales, is leaving the tech behemoth to become CEO ...

According to Mordor Intelligence forecasts, the events industry in Vietnam could reach $7.8 billion by the end of 2025 and ...

Geopolitics are a major driver of the deglobalisation now being spearheaded by the United States. But there are also economic ...

With a faster, more reliable and lower-cost solution, Elegen and Nutcracker Therapeutics aim to democratize PCTs, making them accessible to more developers and saving critical time for cancer patients ...

The ongoing battle between social media platforms and gambling operators has reached a tipping point as Meta implements ...

While technology has revolutionised how we work, it's also made it harder to switch off. This “always-on” culture is ...

Glenmark Pharmaceuticals shares rallied 10% on Friday to reach a record high after its biotech subsidiary signed a ...

A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.

Bitcoin's price has climbed about 26% so far in 2025 Key Takeaways. Several cryptocurrency-related stocks got a lift from ...

Shares of Glenmark Pharmaceuticals jumped 10% in early trade on Friday, a day after a unit of the Indian drugmaker signed an exclusive licensing deal with U.S. peer AbbVie for its cancer treatment.

Only one antibiotic – Sulbactam-durlobactam (brand name: Xacduro) – was effective against CRAB. Approved by US regulators in ...

Frontloading of cargo resulted in an increase in US imports by air in April and May as companies looked to get ahead of the ...